The occurrence of immune-related adverse events indicates better efficacy of immune checkpoint blockade in solid tumors: A systematic review and meta-analysis

被引：0
|
作者：
Yang, Xu
Wang, Dongxu
Lin, Jianzhen
Xiong, Jianping
Long, Junyu
Bai, Yi
Bian, Jin
Huang, Hanchun
Yang, Xiaobo
Mao, Yilei
Sang, Xinting
Zhao, Haitao
机构：
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China
[2] Peking Union Med, Beijing, Peoples R China
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-4992
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4992
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Immune-related adverse events and efficacy outcomes in patients treated with immunotherapy: A systematic review and meta-analysis
    Druyts, Eric
    Boye, Mark
    Agg, Himani
    Muehlenbein, Catherine
    Frederickson, Andrew
    Bayt, Theresa
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [22] Meta-analysis of immune-related adverse events of immune checkpoint inhibitor therapy in cancer patients
    Song, Peng
    Zhang, Dingding
    Cui, Xiaoxia
    Zhang, Li
    THORACIC CANCER, 2020, 11 (09) : 2406 - 2430
  • [23] Immune-related adverse events of immune checkpoint inhibitors: a review
    Yin, Qinan
    Wu, Liuyun
    Han, Lizhu
    Zheng, Xingyue
    Tong, Rongsheng
    Li, Lian
    Bai, Lan
    Bian, Yuan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [24] Safety and Efficacy of the Rechallenge of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer: A Systemic Review and Meta-Analysis
    Zhao, Qing
    Zhang, Jianwei
    Xu, Lingyi
    Yang, Huaxia
    Liang, Naixin
    Zhang, Li
    Zhang, Fengchun
    Zhang, Xuan
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [25] Not all immune-checkpoint inhibitors are created equal: Meta-analysis and systematic review of immune-related adverse events in cancer trials
    El Osta, B.
    Hu, F.
    Sadek, R.
    Chintalapally, R.
    Tang, S. -C.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 119 : 1 - 12
  • [26] Incidence of Cutaneous Immune-Related Adverse Events and Outcomes in Immune Checkpoint Inhibitor-Containing Regimens: A Systematic Review and Meta-Analysis
    Curkovic, Nina B.
    Bai, Kun
    Ye, Fei
    Johnson, Douglas B.
    CANCERS, 2024, 16 (02)
  • [27] Management and Outcomes of Hematological Immune-related Adverse Events: Systematic Review and Meta-analysis
    Wilson, Nathaniel R.
    Lockhart, Jonathan R.
    Garcia-Perdomo, Herney A.
    Oo, Thein H.
    Rojas-Hernandez, Cristhiam M.
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (01) : 13 - 24
  • [28] Management of immune-related adverse events resulting from immune checkpoint blockade
    Baroudjian, Barouyr
    Arangalage, Dimitri
    Cuzzubbo, Stefania
    Hervier, Baptiste
    Lebbe, Celeste
    Lorillon, Gwenael
    Tazi, Abdellatif
    Zalcman, Gerard
    Bouattour, Mohamed
    Liote, Frederic
    Gautier, Jean-Francois
    Brosseau, Solenn
    Lourenco, Nelson
    Delyon, Julie
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (03) : 209 - 222
  • [29] Treating Cutaneous Immune-Related Adverse Events from Immune Checkpoint Blockade
    Adusumilli, Nagasai C.
    Friedman, Adam J.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2021, 20 (10) : 1133 - 1134
  • [30] The incidence of thyroid-related adverse events in solid tumors receiving immune checkpoint blockade with curative intent: A meta-analysis
    Zhou, Susu
    Horita, Nobuyuki
    Shao, Theresa
    Harrington, Matthew
    Fujiwara, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345